Ginna Laport
Hematology & Oncology
Credentials: · ·
History
Research
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Cancer Discovery · 2020 · 289 citations
JAMA · 2011 · 264 citations
Protective conditioning for acute graft-versus-host disease
New England Journal of Medicine · 2005 · 252 citations
25 papers
21 papers
20 papers
20 papers
15 papers
14 papers
13 papers
13 papers
Grants
- 2001–2017
BMT Clinical Trial Network at Stanford
National Heart, Lung, and Blood Institute · U10
Contact PI · $532.4K · Stanford University
- 2001–2011
BMT Clincal Trial Network at Stanford
National Heart, Lung, and Blood Institute · U01
Contact PI · $1M · Stanford University
Clinical trials
- 2002–2009
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Principal investigator · Terminated
Stanford University
- 2001–2010
Principal investigator · Completed
Stanford University
- 2001–2010
Haploid Allogeneic Transplant Using the CliniMACS System
Principal investigator · Terminated · Phase 2
Ginna Laport
- 1996–2005
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
Principal investigator · Completed · Phase 1, Phase 2
Stanford University